Respiratory Viral Testing
Cayman Chemical RSV F ProteIn EXrAClular D
Source: Recombinant C-terminal His-tagged RSV F protein extracellular domain expressed in insect cells • Amino acids: 22-529 • MW: 57.8 kDa
Sino Biological Human respiratory syncytial virus (RSV) (A, rsb1734) glycoprotein G / RSV-G Protein (95% Homology) (His & AVI Tag), Biotinylated
A DNA sequence encoding the glycoprotein G extracellular domain (Asn66-Arg297) of human respiratory syncytial virus A (AMA67228.1) was expressed with a C-terminal polyhistidine tag followed by an AVI tag. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed.
ATCC Human Respiratory Syncytial Virus B (Strain B1), Frozen Viral Isolate (VR-3381)
Human respiratory syncytial virus B (strain B1) is a frozen viral isolate used for respiratory disease and virology research. It was isolated in 1985 from a human in West Virginia and has been developed through multiple passages in Vero cells.
- Organism/strain: Human respiratory syncytial virus B (B1).
- Isolation: 1985, West Virginia, United States.
- Propagation cell line: Vero cells.
- Development: multiple passages in cell culture.
- Form: frozen viral preparation for propagation in cell culture.
![Apexbio Technology LLC Fusion glycoprotein (92-106) [Human respiratory syncytial virus] 5mg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000096620.png-250.jpg)
Apexbio Technology LLC Fusion glycoprotein (92-106) [Human respiratory syncytial virus] 5mg
Fusion glycoprotein 92-106 Human respiratory syncytial virus is a synthetic peptide fragment derived from the Human respiratory syncytial virus (HRSV) fusion glycoprotein This peptide is commonly utilized as an antigenic reference in immunological research vaccine design and therapeutic antibody development studies Fusion glycoprotein 92-106 Human respiratory syncytial virus is applied primarily for its immunogenic properties in experimental settings Based on these characteristics Fusion glycoprotein 92-106 Human respiratory syncytial virus holds research potential in immunological assays vaccine development and therapeutic antibody screening related to HRSV
American Research Products Inc Anti RSV F F0 32.4K
Anti-RSV F/Fusion glycoprotein F0 (32 4K) Research Grade
Roche Diagnostics cobas eplex Respiratory Pathogen Panel 2, multiplexed nucleic acid test, designed for nasopharyngeal swab specimens, tests for >20 pathogens, 12 tests per kit
cobas eplex Respiratory Pathogen Panel 2, multiplexed nucleic acid test, designed for nasopharyngeal swab specimens, tests for >20 pathogens, 12 tests per kit
Sino Biological Human respiratory syncytial virus (RSV) (strain A2, strain Long) Nucleoprotein Protein (His & AVI Tag), Biotinylated
A DNA sequence encoding the Human respiratory syncytial virus (RSV) (strain A2, strain Long) Nucleoprotein (P03418) (Met1-Leu391) was expressed with a C-terminal polyhistidine tag followed by an AVI tag. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed.
Cayman Chemical RSV F ProteIn ChImRIc Moncl
Immunogen: Recombinant human-targeted RSV F • Host: Chimeric Monoclonal Antibody • Species Reactivity: (+) RSV • Cross Reactivity: (+) F protein • Applications: ELISA
Sino Biological Human respiratory syncytial virus (RSV) Nucleoprotein Protein (AVI & His Tag), Biotinylated
A DNA sequence encoding the Human respiratory syncytial virus (RSV) Nucleoprotein (Q6V2F2) (Met1-Leu391) was expressed with an N-terminal polyhistidine tagged AVI tag. The expressed protein was biotinylated in vivo by the Biotin-Protein ligase (BirA enzyme) which is co-expressed.
Cayman Chemical ANTIBODY VP-14637 1mg
An RSV inhibitor that demonstrates antiviral activity with an EC50 value of 1.4 nM; interferes directly with RSV fusion (EC50 = 5.4 nM), binding to the viral F protein
American Research Products Inc Anti RSV F F0 01.4B
Anti-RSV F/Fusion glycoprotein F0 (01 4B) Research Grade